94 related articles for article (PubMed ID: 20925433)
21. Is the cancer stem cell population "a player" in multi-drug resistance?
Drewa T; Styczynski J; Szczepanek J
Acta Pol Pharm; 2008; 65(4):493-500. PubMed ID: 19051593
[TBL] [Abstract][Full Text] [Related]
22. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
[TBL] [Abstract][Full Text] [Related]
23. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications.
Wong RS; Cheong SK
Malays J Pathol; 2012 Dec; 34(2):77-88. PubMed ID: 23424769
[TBL] [Abstract][Full Text] [Related]
24. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
25. Berbamine derivatives: a novel class of compounds for anti-leukemia activity.
Xie J; Ma T; Gu Y; Zhang X; Qiu X; Zhang L; Xu R; Yu Y
Eur J Med Chem; 2009 Aug; 44(8):3293-8. PubMed ID: 19285759
[TBL] [Abstract][Full Text] [Related]
26. A PDE model for imatinib-treated chronic myelogenous leukemia.
Kim PS; Lee PP; Levy D
Bull Math Biol; 2008 Oct; 70(7):1994-2016. PubMed ID: 18663536
[TBL] [Abstract][Full Text] [Related]
27. Experimental basis of antileukaemic chemotherapy.
Messner HA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():20-5. PubMed ID: 2653504
[No Abstract] [Full Text] [Related]
28. The potential of targeting malignant stem cells as a treatment for leukemia.
Jordan CT
Future Oncol; 2005 Apr; 1(2):205-7. PubMed ID: 16555992
[TBL] [Abstract][Full Text] [Related]
29. The leukemic stem cell.
Jordan CT
Best Pract Res Clin Haematol; 2007 Mar; 20(1):13-8. PubMed ID: 17336250
[TBL] [Abstract][Full Text] [Related]
30. Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.
Aksenov AV; Smirnov AN; Magedov IV; Reisenauer MR; Aksenov NA; Aksenova IV; Pendleton AL; Nguyen G; Johnston RK; Rubin M; De Carvalho A; Kiss R; Mathieu V; Lefranc F; Correa J; Cavazos DA; Brenner AJ; Bryan BA; Rogelj S; Kornienko A; Frolova LV
J Med Chem; 2015 Mar; 58(5):2206-20. PubMed ID: 25671501
[TBL] [Abstract][Full Text] [Related]
31. [Induced pluripotent stem cells from leukemia patients as a platform for dissecting pathogenesis].
Kurokawa M; Miyauchi M
Rinsho Ketsueki; 2014 Oct; 55(10):2202-7. PubMed ID: 25297788
[No Abstract] [Full Text] [Related]
32. Test this patient's leukemic stem cells in a non-clonogenic chemosensitivity assay, treat according to standard protocols.
Hofmann V; Berens ME
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1119-21. PubMed ID: 6541132
[No Abstract] [Full Text] [Related]
33. [Differentiation--inducing therapy].
Kizaki M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():207-10. PubMed ID: 23133954
[No Abstract] [Full Text] [Related]
34. Editorial : novel and emerging drugs for leukemias.
Robak T
Curr Cancer Drug Targets; 2012 Jun; 12(5):453-7. PubMed ID: 22483152
[TBL] [Abstract][Full Text] [Related]
35. Autophagy and Leukemia.
Zheng Z; Wang L; Cheng S; Wang Y; Zhao W
Adv Exp Med Biol; 2020; 1207():601-613. PubMed ID: 32671778
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapy can induce relapse in some patients with leukemia.
Printz C
Cancer; 2020 Apr; 126(8):1601. PubMed ID: 32220079
[No Abstract] [Full Text] [Related]
37. Can we finally target the leukemic stem cells?
Jordan CT
Best Pract Res Clin Haematol; 2008 Dec; 21(4):615-20. PubMed ID: 19041600
[TBL] [Abstract][Full Text] [Related]
38. Human trials of new cancer therapy begin.
Marx JL
Science; 1987 May; 236(4803):778-9. PubMed ID: 3554509
[No Abstract] [Full Text] [Related]
39. Overcoming drug resistance: targeting more than one site.
Karp JE; Mookerjee BP
Leuk Res; 2002 Jan; 26(1):107-9. PubMed ID: 11734308
[No Abstract] [Full Text] [Related]
40. Differentiation factors.
Gabrilove JL
Semin Oncol; 1986 Jun; 13(2):228-33. PubMed ID: 3520829
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
